Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
BAY 87-2243
Inhibition of mTOR by Temsirolimus improves performance on four different behavioral tasks and decreases aggregate formation in a mouse model of Huntington disease
InChi: InChI=1S/C34H46ClN3O10/c1-18-11-10-12-26(45-9)34(43)17-25(46-32(42)36-34)19(2)30-33(5
InChi: InChI=1S/C6H10O4/c1-4(6(9)10)2-3-5(7)8/h4H
InChi: InChI=1S/C45H82N12O14S2/c1-24(2)21-31(42(67)54-32(22-35(60)61)43(68)56-33(23-58)45(70)71)55-44(69)36(25(3)4)57-41(66)28(12-8-10-18-47)52-38(63)27(11-7-9-17-46)51-40(65)30(16-20-73-6)53-39(64)29(13-14-34(49)59)50-37(62)26(48)15-19-72-5/h24-33
Antitumor agent-2 Size:Contact [email protected] for quotation BAY 87-2243Antitumor agent 2 is sourced from patent CN102250203, compound 6a r, has antitumor action and anti inflammatory action. Product information CAS Number: 1351163 57 9 Molecular Weight: 558. 71 Formula: C33H42N4O4 Chemical Name: benzyl (2S) 2 [(2S) 2 [(15S) 12,12 dimethyl 14 oxo 8,11,13 triazatetracyclo[7. 7. 0. 0,. 0,]hexadeca 1(9),2,4,6 tetraen 13 yl] 4 methylpentanamido] 3 methylbutanoate Smiles: